How URAT1 inhibitors can shape the future of chronic gout treatment: a narrative review of uricosurics past and present
用户aKgJC6g3RnhA
28天前
51
10
已完结
1. 系统已在2025-03-31 11:30:34对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
RT Keenan, Z Shen, S Yan, LT Yeh, MH Pillinger
2024
explorationpub.com
… Ruzinurad is an investigational agent that has been evaluated in two phase 2 trials, both … to receive once-daily ruzinurad, benzbromarone, or placebo [73]. Ruzinurad was superior to …
